News
-
-
PRESS RELEASE
Capital B confirms the acquisition of 5 BTC for EUR0.4 million, the holding of a total of 2,823 BTC, and a BTC Yield of 1,658.5% YTD
Capital B announces final conversions of OCA B-01 and OCA B-02 into new ordinary shares, subscription by Ludovic Chechin-Laurans, and conversion of BSA 2025-01. Details on BTC performance and acquisitions also disclosed -
-
-
-
PRESS RELEASE
Straumann Group outlines its mid-term growth strategy to accelerate market shares, strengthen profitability and increase cash generation
Straumann Group presented its mid-term growth strategy at Capital Markets Day, focusing on accelerating market shares, profitability, and cash generation through digital innovation and ecosystem -
PRESS RELEASE
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets -
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron receive EU approval for Dupixent as targeted medicine for chronic spontaneous urticaria, significantly reducing itch and hives compared to placebo -
-
